Product Highlight - Opalmon
Active ingredient: Limaprost 5 µg of limaprost alfadex
- Improvement of subjective symptoms (pain and numbness of lower legs) and gait ability associated with acquired lumbar spinal canal stenosis (in patients with bilateral intermittent claudication showing normal SLR test result)
- Improvement of various ischemic symptoms such as ulcer, pain and feeling of coldness associated with thromboangiitis obliterans
Dosage & Administration:
Lumbar spinal stenosis: 15 µg daily in three divided doses
Improvement of various ischemic symptoms: 30 µg daily in three divided doses
Presentation: Each press-through blister contains 21 tablets, contained in box of 10 blister sheets (210 tablets).